• ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmun... GlobeNewswire Mon, 05 May 2025 11:03:59 GMT
• Macular Edema and Macular Degeneration Market Comprehensive openPR.com Wed, 30 Apr 2025 12:41:00 GMT
• alimera sciences announces change to smpc allowing all united kingdom (great britain and northern ireland) qualified ophthalmic he... PharmiWeb.com Fri, 21 Mar 2025 09:28:33 GMT
• alimera sciences announces change to smpc allowing all united kingdom (great britain and northern ireland) qualified ophthalmic he... PharmiWeb.com Thu, 20 Mar 2025 07:00:00 GMT
• ani pharmaceuticals announces the launch of nitazoxanide tablets GlobeNewswire Wed, 19 Mar 2025 07:00:00 GMT
• macular edema market size, trends & growth analysis | forecast openPR.com Mon, 17 Mar 2025 07:00:00 GMT
• alimera sciences reports record fourth quarter and 2018 results ACCESS Newswire Fri, 07 Mar 2025 20:12:34 GMT
• actinic keratosis market forecast 2034: ema, pdma, fda approvals, prevalence, clinical trials, treatment, medication, therapies, a... The Globe and Mail Fri, 07 Mar 2025 12:21:26 GMT
• alimera sciences announces multiple posters and a podium presentation of clinical data for iluvien(r) to be presented at the assoc... ACCESS Newswire Thu, 06 Mar 2025 15:11:34 GMT
• ocular drug delivery technology market: advancing from us$16.3 bn in 2023 to us$30.2 bn by 2034 - tmr study Newstrail Mon, 03 Mar 2025 09:14:32 GMT
• alimera sciences announces approval for iluvien(r) in lebanon ACCESS Newswire Sun, 02 Mar 2025 11:08:21 GMT
• ani pharmaceuticals reports record fourth quarter and full-year 2024 financial results TradingView Fri, 28 Feb 2025 08:00:00 GMT
• investor network: alimera sciences inc to host earnings call ACCESS Newswire Fri, 28 Feb 2025 05:48:18 GMT
• alimera sciences announces data from 19 iluvien(r) studies to be presented at 2018 arvo ACCESS Newswire Tue, 28 Jan 2025 09:57:23 GMT
• generics player ani pharmaceuticals strengthens rare disease segment with $380m alimera sciences deal MSN Mon, 20 Jan 2025 05:19:43 GMT
• anip - ani pharmaceuticals, inc. latest stock news & market updates StockTitan Mon, 13 Jan 2025 16:12:00 GMT
• ani pharmaceuticals announces the fda approval and launch of prucalopride tablets with 180-day cgt exclusivity The Manila Times Thu, 02 Jan 2025 08:00:00 GMT
• shareholder alert: the m&a class action firm investigates merger of the alimera sciences, inc. - alim GuruFocus.com Wed, 11 Dec 2024 00:19:40 GMT
• uveitis market forecasted for major expansion by 2031 | novartis openPR Thu, 05 Dec 2024 08:00:00 GMT
• diabetic macular edema market key players analysis - novartis openPR Thu, 21 Nov 2024 08:00:00 GMT
• ani pharmaceuticals hits record q3 revenue, cortrophin sales surge 77% StockTitan Fri, 08 Nov 2024 08:00:00 GMT
• ani pharmaceuticals reports record third quarter 2024 financial results and raises 2024 guidance Yahoo Finance Fri, 08 Nov 2024 08:00:00 GMT
• ani pharmaceuticals announces the fda approval and launch of estradiol gel, 0.06% Yahoo Finance Fri, 25 Oct 2024 07:00:00 GMT
• ani pharmaceuticals price target raised to $62 from $60 at truist Yahoo Finance Wed, 23 Oct 2024 07:00:00 GMT
• ani pharmaceuticals: a rare garp stock in an overbought market Seeking Alpha Fri, 11 Oct 2024 07:00:00 GMT
• stocknews.com begins coverage on alimera sciences (nasdaq:alim) Defense World Tue, 08 Oct 2024 23:17:42 GMT
• stonepine capital management llc sells 539,256 shares of alimera sciences, inc. (nasdaq:alim) Defense World Tue, 01 Oct 2024 18:14:45 GMT
• 20,394 shares in alimera sciences, inc. (nasdaq:alim) acquired by rhumbline advisers Defense World Tue, 01 Oct 2024 08:03:45 GMT
• alimera sciences (nasdaq:alim) coverage initiated at stocknews.com Defense World Tue, 01 Oct 2024 05:18:12 GMT
• ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2% GlobeNewswire Thu, 26 Sep 2024 07:00:00 GMT
• glazer capital llc makes new $3.07 million investment in alimera sciences, inc. (nasdaq:alim) Defense World Tue, 24 Sep 2024 21:37:57 GMT
• alimera sciences (nasdaq:alim) coverage initiated at stocknews.com MarketBeat Sun, 22 Sep 2024 09:41:01 GMT
• analysts’ new coverage for september 22nd (alim, ams, anss, big, carv, chek, cizn, cmcm, cpsh, fms) Defense World Sun, 22 Sep 2024 07:00:00 GMT
• alimera sciences (nasdaq:alim) research coverage started at stocknews.com Defense World Sun, 22 Sep 2024 06:28:51 GMT
• ani pharmaceuticals completes acquisition of alimera sciences Investing.com Sat, 21 Sep 2024 06:46:52 GMT
• ani pharmaceuticals completes acquisition of alimera sciences Investing.com Fri, 20 Sep 2024 07:00:00 GMT
• princeton-based ani pharmaceuticals completes acquisition of alimera sciences ROI-NJ Wed, 18 Sep 2024 07:00:00 GMT
• alimera sciences, inc. (nasdaq:alim) short interest down 13.8% in august Defense World Tue, 17 Sep 2024 08:26:38 GMT
• ANI Pharmaceuticals completes acquisition of Alimera Sciences Healio Tue, 17 Sep 2024 07:00:00 GMT
• alimera sciences completes merger with ani pharmaceuticals Investing.com India Tue, 17 Sep 2024 07:00:00 GMT
• ani pharmaceuticals finalizes acquisition of alimera sciences Investing.com Tue, 17 Sep 2024 03:58:14 GMT
• alimera sciences, inc. (nasdaq:alim) short interest down 13.8% in august MarketBeat Mon, 16 Sep 2024 15:21:37 GMT
• ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences GlobeNewswire Mon, 16 Sep 2024 07:00:00 GMT
• ani pharmaceuticals initiates closing of acquisition of alimera sciences GlobeNewswire Mon, 16 Sep 2024 07:00:00 GMT
• ani pharmaceuticals completes acquisition of alimera sciences TipRanks Mon, 16 Sep 2024 07:00:00 GMT
• ani pharmaceuticals completes purchase of alimera sciences (nasdaq:alim) Seeking Alpha Mon, 16 Sep 2024 07:00:00 GMT
• alimera sciences completes merger with ani pharmaceuticals Investing.com Mon, 16 Sep 2024 07:00:00 GMT
• ani pharmaceuticals finalizes acquisition of alimera sciences Investing.com Mon, 16 Sep 2024 07:00:00 GMT
• alimera sciences, inc. (nasdaq:alim) sees large drop in short interest MarketBeat Mon, 16 Sep 2024 07:00:00 GMT
• alimera sciences (nasdaq:alim) stock passes above 200 day moving average of $4.34 Defense World Sat, 14 Sep 2024 09:52:39 GMT
• alimera sciences (nasdaq:alim) shares cross above 200-day moving average of $4.34 MarketBeat Sat, 14 Sep 2024 07:38:57 GMT
• alimera sciences (nasdaq:alim) stock crosses above 200-day moving average of $4.34 MarketBeat Sat, 14 Sep 2024 07:00:00 GMT
• alimera sciences (nasdaq:alim) now covered by stocknews.com MarketBeat Sat, 14 Sep 2024 06:34:59 GMT
• stocknews.com initiates coverage on alimera sciences (nasdaq:alim) MarketBeat Sat, 14 Sep 2024 06:34:59 GMT
• alimera sciences (nasdaq:alim) now covered by analysts at stocknews.com Defense World Sat, 14 Sep 2024 06:18:58 GMT
• ani pharmaceuticals launches promethazine hydrochloride and dextromethorphan hydrobromide oral solution StockTitan Fri, 13 Sep 2024 07:00:00 GMT
• Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock? Yahoo Finance Thu, 12 Sep 2024 07:00:00 GMT
• alimera sciences, inc. (nasdaq:alim): when will it breakeven? Yahoo Finance Thu, 12 Sep 2024 07:00:00 GMT
• alimera sciences inc. [alim] gain 20.14% so far this year. what now? The DBT News Wed, 11 Sep 2024 17:08:01 GMT
• alimera seeks court order to finalize ani pharmaceuticals merger Investing.com Wed, 11 Sep 2024 09:36:54 GMT
• ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger Business Wire Wed, 11 Sep 2024 07:00:00 GMT
• alimera sciences: deal closing after all, cvr still attractive (nasdaq:alim) Seeking Alpha Wed, 11 Sep 2024 07:00:00 GMT
• ani pharmaceuticals falls amid truist downgrade on delayed alimera deal close Seeking Alpha Wed, 11 Sep 2024 07:00:00 GMT
• alimera sciences takes legal action against ani pharmaceuticals to enforce merger agreement Drug Store News Wed, 11 Sep 2024 07:00:00 GMT
• ani pharmaceuticals, alimera sciences merger to close on september 16 TipRanks Wed, 11 Sep 2024 07:00:00 GMT
• ani pharmaceuticals, alimera set merger closing for september 16 Investing.com Wed, 11 Sep 2024 07:00:00 GMT
• alimera sciences secures executive tax reimbursements by investing.com Investing.com UK Tue, 10 Sep 2024 21:36:00 GMT
• alimera sciences plunges after it sues ani pharmaceuticals to close deal MSN Tue, 10 Sep 2024 18:58:51 GMT
• alimera sciences inc. (alim) stock: a 52-week tale of drops and gains The InvestChronicle Tue, 10 Sep 2024 18:51:34 GMT
• alimera seeks court order to finalize ani pharmaceuticals merger by investing.com Investing.com UK Tue, 10 Sep 2024 13:38:00 GMT
• Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement Business Wire Tue, 10 Sep 2024 07:00:00 GMT
• upper peninsula abc 10 - news, sports, weather and more from michigan's upper peninsula Financial Content Tue, 10 Sep 2024 07:00:00 GMT
• alimera sciences falls after it sues ani pharmaceuticals to close deal (update) Seeking Alpha Tue, 10 Sep 2024 07:00:00 GMT
• ani pharmaceuticals provides update on closing of acquisition of alimera sciences Yahoo Finance Tue, 10 Sep 2024 07:00:00 GMT
• ani says working in ‘good faith’ to close alimera acquisition TipRanks Tue, 10 Sep 2024 07:00:00 GMT
• alimera sciences down on filing lawsuit against ani pharma to close deal XM Tue, 10 Sep 2024 07:00:00 GMT
• alimera sciences, inc.(nasdaqgm: alim) dropped from s&p tmi index Marketscreener.com Tue, 10 Sep 2024 00:52:14 GMT
• alimera sciences, inc.(nasdaqgm: alim) dropped from s&p tmi index Marketscreener.com Mon, 09 Sep 2024 07:00:00 GMT
• alimera sciences inc.’s banking’s 100-day moving average at 4.49: will the stock break through? The InvestChronicle Fri, 06 Sep 2024 18:13:42 GMT
• alimera sciences (nasdaq:alim) receives new coverage from analysts at stocknews.com MarketBeat Fri, 06 Sep 2024 06:35:56 GMT
• market resilience: alimera sciences inc. (alim) finishes weak at 5.54, down -0.18 The Dwinnex Fri, 30 Aug 2024 14:33:43 GMT
• alimera sciences inc. inc. (alim) price performance: a technical analysis perspective The InvestChronicle Fri, 30 Aug 2024 13:42:07 GMT
• FDA sends warning letters to eye implant, bone matrix manufacturers Regulatory Affairs Professionals Society | RAPS Fri, 30 Aug 2024 07:00:00 GMT
• alimera sciences (nasdaq:alim) shares pass above 200-day moving average of $4.19 Defense World Thu, 29 Aug 2024 15:26:45 GMT
• alimera sciences (nasdaq:alim) share price crosses above 200-day moving average of $4.19 MarketBeat Thu, 29 Aug 2024 14:11:02 GMT
• alimera sciences (nasdaq:alim) now covered by analysts at stocknews.com MarketBeat Thu, 29 Aug 2024 06:27:28 GMT
• alimera sciences (nasdaq:alim) coverage initiated at stocknews.com Defense World Thu, 29 Aug 2024 06:25:06 GMT
• ani pharmaceuticals to further expand rare disease business through acquisition of alimera sciences substack.com Wed, 28 Aug 2024 07:00:00 GMT
• EyePoint dinged with FDA warning letter over manufacturing shortfalls tied to eye implant Fierce Pharma Tue, 27 Aug 2024 07:00:00 GMT
• alimera sciences (nasdaq:alim) now covered by analysts at stocknews.com MarketBeat Wed, 21 Aug 2024 06:22:26 GMT
• alimera sciences (nasdaq:alim) research coverage started at stocknews.com Defense World Wed, 21 Aug 2024 06:16:59 GMT
• alimera sciences, inc. (nasdaq:alim) shares purchased by vanguard group inc. MarketBeat Mon, 19 Aug 2024 08:49:00 GMT
• vanguard group inc. grows stake in alimera sciences, inc. (nasdaq:alim) MarketBeat Mon, 19 Aug 2024 08:49:00 GMT
• alimera sciences investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price... Business Wire Mon, 19 Aug 2024 07:00:00 GMT
• shareholder alert: ademi llp investigates whether alimera sciences, inc. has obtained a fair price for its public shareholders Longview News-Journal Wed, 14 Aug 2024 16:37:30 GMT
• deltec asset management llc invests $690,000 in alimera sciences, inc. (nasdaq:alim) MarketBeat Wed, 14 Aug 2024 07:00:00 GMT
• stocknews.com initiates coverage on alimera sciences (nasdaq:alim) Defense World Tue, 13 Aug 2024 06:44:07 GMT
• stocknews.com begins coverage on alimera sciences (nasdaq:alim) MarketBeat Tue, 13 Aug 2024 06:43:26 GMT
• earnings call: ani pharmaceuticals reports strong q2 growth, raises guidance by investing.com Investing.com Australia Sun, 11 Aug 2024 07:00:00 GMT
• earnings call: ani pharmaceuticals reports strong q2 growth, raises guidance by investing.com Investing.com Canada Sat, 10 Aug 2024 15:32:17 GMT
• should you invest on alimera sciences, inc. (alim) right now? Yahoo Finance Fri, 09 Aug 2024 07:00:00 GMT
• alimera sciences (nasdaq:alim) posts earnings results, misses expectations by $0.02 eps Defense World Thu, 08 Aug 2024 15:24:14 GMT
• alimera sciences (nasdaq:alim) posts quarterly earnings results, misses expectations by $0.02 eps MarketBeat Wed, 07 Aug 2024 21:02:37 GMT
• alimera sciences (nasdaq:alim) now covered by stocknews.com American Banking and Market News Wed, 07 Aug 2024 06:10:52 GMT
• ani pharmaceuticals reports second quarter 2024 financial results and raises 2024 guidance GlobeNewswire Tue, 06 Aug 2024 07:00:00 GMT
• alimera sciences (alim) reports q2 loss, tops revenue estimates Yahoo Finance Tue, 06 Aug 2024 07:00:00 GMT
• alim stock earnings: alimera sciences misses eps, beats revenue for q2 2024 InvestorPlace Tue, 06 Aug 2024 00:15:46 GMT
• alimera sciences (nasdaq:alim) coverage initiated at stocknews.com MarketBeat Mon, 05 Aug 2024 08:02:11 GMT
• alimera sciences (nasdaq:alim) receives new coverage from analysts at stocknews.com MarketBeat Mon, 05 Aug 2024 08:02:11 GMT
• alimera sciences (nasdaq:alim) research coverage started at stocknews.com Defense World Mon, 05 Aug 2024 07:00:00 GMT
• anip stock: tezruly approved, 2 ndas and alimera acquisition could triple revenue (anip) Seeking Alpha Fri, 02 Aug 2024 07:00:00 GMT
• ophthalmic implant products market is booming worldwide |abbive, alimera sciences, bausch + lomb, eyepoint pharmaceutica – moose g... Moose Gazette Tue, 30 Jul 2024 17:46:25 GMT
• intravitreal implant market rapid growth at deep value price :abbive, alimera sciences, bausch + lomb, eyepoint pharmace – moose g... Moose Gazette Tue, 30 Jul 2024 17:42:19 GMT
• ophthalmic implant products market – 37% of growth to originate from apac -abbive, alimera sciences, bausch + lomb, eyep – moose g... Moose Gazette Tue, 30 Jul 2024 16:46:05 GMT
• ophthalmic implant products industry is expected to reach $8 billion by 2030 -abbive, alimera sciences, bausch + lomb, e – moose g... Moose Gazette Tue, 30 Jul 2024 07:00:00 GMT
• alimera sciences (nasdaq:alim) research coverage started at stocknews.com MarketBeat Sun, 28 Jul 2024 05:25:32 GMT
• alimera sciences (nasdaq:alim) receives new coverage from analysts at stocknews.com Defense World Sun, 28 Jul 2024 05:21:36 GMT
Alimera Sciences, Inc(NASDAQ:ALIM) 
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of ...
Website: http://www.alimerasciences.com
Founded: 2003
Full Time Employees: 122
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic